Clinical Trial: Is [18F]-DPA-714 PET a Good Marker of Neuroinflammation in Autoimmune Encephalitis?

U.S., March 24 -- ClinicalTrials.gov registry received information related to the study (NCT07488117) titled 'Is [18F]-DPA-714 PET a Good Marker of Neuroinflammation in Autoimmune Encephalitis?' on March 10.

Brief Summary: This study aims to evaluate the effectiveness of [18F]-DPA-714 PET imaging in detecting neuroimmune activity in patients with autoimmune encephalitis (AE). The primary objective is to compare [18F]-DPA-714 binding in AE patients to healthy controls.

Study Start Date: March, 2026

Study Type: INTERVENTIONAL

Condition: Autoimmune Encephalitis (AE)

Intervention: OTHER: TEP with radioligand EAI 714

60-minutes [18F]-DPA-714 PET imaging

Recruitment Status: NOT_YET_RECRUITING

Sponsor: University Hospital, Toulouse

Disc...